Garwood Medical Devices recently announced that it and a University of Buffalo research team have won a $749,000 federal grant to evaluate a medical device to prevent, control, and eliminate bacterial biofilm infections associated with orthopedic implants.
Garwood is licensing the technology behind the BioPrax device, a cathodic voltage-controlled electrical stimulation (CVCES) patented by the University of Buffalo and Syracuse University. When an infection is present, BioPrax is designed to deliver the electrical stimulation to a metal implant, such as a prosthetic knee, where it has an antibacterial effect designed to kill the infecting bacteria.
Get the full story on our sister site, Medical Design & Outsourcing.